Axon Enterprise Stock Today
AXON Stock | USD 539.99 14.83 2.67% |
PerformanceVery Weak
| Odds Of DistressVery Low
|
Axon Enterprise is selling at 539.99 as of the 19th of March 2025; that is 2.67% down since the beginning of the trading day. The stock's open price was 554.82. Axon Enterprise has only four percent chance of going through some form of financial distress over the next 2 years, but has generated negative returns over the last 90 days. Note, on February 14, 2025, Representative Rob Bresnahan of US Congress acquired under $15k worth of Axon Enterprise's common stock.
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices under the TASER brand in the United States and internationally. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona. Axon Enterprise operates under Aerospace Defense classification in the United States and is traded on NASDAQ Exchange. The company has 77.66 M outstanding shares of which 2.36 M shares are presently shorted by private and institutional investors with about 2.15 trading days to cover. More on Axon Enterprise
Moving together with Axon Stock
0.67 | BA | Boeing Sell-off Trend | PairCorr |
0.73 | PL | Planet Labs PBC Earnings Call Shortly | PairCorr |
Moving against Axon Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Axon Stock Highlights
President Federal | Richard II |
Thematic Ideas | (View all Themes) |
Old Name | Axon Holdings S.A. |
Business Concentration | Aerospace & Defense, Industrials, SP 500 Index, NASDAQ 100 Equal, Nasdaq 100, NASDAQ 100 Pre, NASDAQ Composite, Aggressive Defence, Defense, Industrials, Aerospace & Defense, Aerospace & Defense, Industrials (View all Sectors) |
Financial Strength |
Axon Enterprise (AXON) is traded on NASDAQ Exchange in USA. It is located in 17800 North 85th Street, Scottsdale, AZ, United States, 85255 and employs 4,100 people. Axon Enterprise is listed under Aerospace & Defense category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 41.94 B. Axon Enterprise conducts business under Aerospace & Defense sector and is part of Industrials industry. The entity has 77.66 M outstanding shares of which 2.36 M shares are presently shorted by private and institutional investors with about 2.15 trading days to cover.
Axon Enterprise currently holds about 377.62 M in cash with 408.31 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.31.
Check Axon Enterprise Probability Of Bankruptcy
Ownership AllocationAxon Enterprise holds a total of 77.66 Million outstanding shares. The majority of Axon Enterprise outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Axon Enterprise to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Axon Enterprise. Please pay attention to any change in the institutional holdings of Axon Enterprise as this could imply that something significant has changed or is about to change at the company. On February 14, 2025, Representative Rob Bresnahan of US Congress acquired under $15k worth of Axon Enterprise's common stock.
Check Axon Ownership Details
Axon Enterprise Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Axon Enterprise market risk premium is the additional return an investor will receive from holding Axon Enterprise long position in a well-diversified portfolio.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.03) | |||
Total Risk Alpha | 0.3046 | |||
Treynor Ratio | (0.12) |
Axon Stock Against Markets
Axon Enterprise Corporate Management
Jeffrey Kunins | Chief Software | Profile | |
Jenner Holden | Chief Officer | Profile | |
Andrea James | Chief Officer | Profile | |
Ruth Sleeter | Chief Officer | Profile | |
Isaiah Fields | Corporate Officer | Profile | |
Erik Lapinski | Senior Relations | Profile |
Already Invested in Axon Enterprise?
The danger of trading Axon Enterprise is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Axon Enterprise is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Axon Enterprise. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Axon Enterprise is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Axon Enterprise offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axon Enterprise's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axon Enterprise Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axon Enterprise Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axon Enterprise. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Axon Stock, please use our How to Invest in Axon Enterprise guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Aerospace & Defense space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axon Enterprise. If investors know Axon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axon Enterprise listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Axon Enterprise is measured differently than its book value, which is the value of Axon that is recorded on the company's balance sheet. Investors also form their own opinion of Axon Enterprise's value that differs from its market value or its book value, called intrinsic value, which is Axon Enterprise's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axon Enterprise's market value can be influenced by many factors that don't directly affect Axon Enterprise's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axon Enterprise's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axon Enterprise is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axon Enterprise's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.